Disease-Related Outcomes and Toxicities of Intensity-Modulated Radiation Therapy Following Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review
ConclusionsP-IMRT produces relatively few higher-grade toxicities, and has reasonable disease-related outcomes, especially when delivering using conventionally-fractionated regimens to doses of 45-54 Gy and exercising careful attention to dose constraints during treatment planning. IMRT can thus be considered in well-selected patients in whom adequate survival following pleurectomy is expected. These data also support the initiation of the phase III NRG-LU006 trial of eP/D and chemotherapy with or without IMRT.
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Asbestosis | Cancer & Oncology | Chemotherapy | Intensity-Modulated Radiation Therapy | Men | Mesothelioma | Radiation Therapy | Study | Toxicology